Home > Compound List > Product Information
Vandetanib_Molecular_structure_CAS_443913-73-3)
Click picture or here to close

Vandetanib

Catalog No. V097100 Name Toronto Research Chemicals
CAS Number 443913-73-3 Website http://www.trc-canada.com
M. F. C22H24BrFN4O2 Telephone +1 (416) 665-9696
M. W. 475.3539632 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage -20°C Freezer Chembase ID: 72478

SYNONYMS

IUPAC name
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
IUPAC Traditional name
vandetanib
Synonyms
4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline
ZD 6474
Zactima
N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine

DATABASE IDS

CAS Number 443913-73-3

PROPERTIES

Certificate of Analysis Download
Apperance Off-White to Pale Yellow Solid
Melting Point 240-243°C
Solubility Methanol
MSDS Link Download
Storage Condition -20°C Freezer

DETAILS

Description (English)
Vandetanib is a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity of Vandetanib plus Docetaxel was assessed in patients with previously treated non-small-cell lung

REFERENCES

  • Bruns, C., et al.: Clin. Cancer Res., 6, 1936 (2000)
  • Hennequin, L., et al.: J. Med. Chem., 45, 1300 (2000)
  • Park, M., et al.: J. Biol. Chem., 278, 50624 (2000)
  • Arao, T., et al.: Cancer Res., 64, 9101 (2000)
  • Prueitt, R., et al.: Int. J. Cancer, 120, 796